Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Second Quarter Financial Results
Go back to Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Second Quarter Financial Results| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 2.23 +0.08 (3.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.15 | 52 Week High | $19.62 | |||
| Open | $2.10 | 52 Week Low | $7.65 | |||
| Day High | $2.24 | P/E | N/A | |||
| Day Low | $2.06 | EPS | $-0.22 | |||
| Volume | 1,757,034 | |||||
